Veraxa Biotech Holding AG
NASDAQ:VRXABiotechnology
-$1.60 today
- Market cap
- $145.65M
- Beta
- -0.40
Volume 0.10M
Average 0.02M
Returns on capital
Veraxa Biotech Holding AG management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Christoph Antz | Co-Founder, Lead Director & CEO | — | 64 | — | — |
Christoph Erkel | Chief Scientific Officer | — | 49 | — | — |
Heinz Schwer | Chief Business Officer | — | 58 | — | — |
Carl von Halem | Principal Financial Officer & Principal Accounting Officer | — | — | 0 | <0.01% |
Raju Willener | Chief Financial Officer | — | — | — | — |
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jul 10, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
5
$125,332.66
Sells
0
$0.00
Net Transaction Value
+$125,332.66
Net buying
Most Active
Gruninger Marc
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Oct 28, 26Oct 28, 2026 | Gruninger Marc Direct | Buy | $9.1K$9,133.00 |
| Oct 27, 26Oct 27, 2026 | Gruninger Marc Direct | Buy | $849.7$849.66 |
| Oct 20, 26Oct 20, 2026 | Ziegler Christoph Samuel Direct | Buy | $32.7K$32,700.00 |
| Aug 27, 26Aug 27, 2026 | Baumann Oliver Rolf Indirect | Buy | $75K$75,000.00 |
| Aug 27, 26Aug 27, 2026 | Antz Christoph Rudiger Direct | Buy | $7.7K$7,650.00 |
Summary
Insiders reported 5 buys worth $125,332.66 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $125,332.66. Gruninger Marc was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Who does Veraxa Biotech Holding AG compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
No competitor data available.
Questions
Management questions
Common questions about VRXA's management, answered from reported figures.
Who manages VRXA?
Veraxa Biotech Holding AG (VRXA) lists 5 active executives. The top listed executive is Christoph Antz, Co-Founder, Lead Director & CEO.
Are VRXA insiders buying or selling?
Recent insider activity shows net buying of $125,332.66.
Continue the stock analysis
Jump to another research area for this company.